- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Investor also decries soda company's acquisitions and governance.
Regulator's sign-off on Office Depot-Office Max deal means another will likely pass muster.
A spending bill measure would dismantle the Lincoln Rule's obligation to divest derivatives.
Big banks need to raise $21 billion.
Insurgent starts contest less than a week after sending harsh letter seeking divestitures, buybacks.
The Senate would need to remove OLA repeal to win Obama signature on bankruptcy reform.
Senator cites 2012 Fed report warning big banks lack up to $15B each to cover catastrophic losses.
Valeant says it can't justify $219 a share offer to shareholders.
Companies have used private detectives for years. Now, dissident shareholders are hiring their own gumshoes. With everybody watching everybody else, at least one group wins: The investigation firms.
Investors will look for response from Zoetis on its investor day scheduled for Nov. 18.